23 August 2005, Hong Kong – LAWFUEL – The Law News Network – Shearman & Sterling’s Hong Kong office advised UBS A.G. as the sole underwriter in the US$96 million initial public offering and NASDAQ listing of 6,400,000 American Depository
Shares representing ordinary shares of China Medical Technologies, Inc.
The company has granted the underwriter the option to purchase up to an
additional 960,000 ADSs.
Based in China, China Medical Technologies, Inc. produces medical
devices using ultrasound technologies to treat solid cancers and tumors.
The company operates through its wholly-owned subsidiary Beijing Yuande
Bio-Medical Engineering Co., Ltd. based in Beijing, China.
The transaction was led by the firm’s Hong Kong capital markets partner
Leiming Chen. Other attorneys in the deal team included partner Larry
Crouch from the firm’s Menlo Park office, New York-based counsel Charles
Gittleman, associates Megan Tang, Huang Ling, Blake Dunlap, Huang Hai,
Ernest Lim, Eileen O’Pray, Russell Sacks and Tanya Sheridan, and legal
assistants Aaron Huang and Angela Zhang.